These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24480530)

  • 1. Implantable cardioverter defibrillator deactivation: a hospice quality improvement initiative.
    Kraynik SE; Casarett DJ; Corcoran AM
    J Pain Symptom Manage; 2014 Sep; 48(3):471-7. PubMed ID: 24480530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deactivation of implantable cardioverter defibrillators in terminal illness and end of life care.
    Kirkpatrick JN; Gottlieb M; Sehgal P; Patel R; Verdino RJ
    Am J Cardiol; 2012 Jan; 109(1):91-4. PubMed ID: 21943937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Original research: deactivation of ICDs at the end of life: a systematic review of clinical practices and provider and patient attitudes.
    Russo JE
    Am J Nurs; 2011 Oct; 111(10):26-35. PubMed ID: 21926561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brief communication: Management of implantable cardioverter-defibrillators in hospice: A nationwide survey.
    Goldstein N; Carlson M; Livote E; Kutner JS
    Ann Intern Med; 2010 Mar; 152(5):296-9. PubMed ID: 20194235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. End-of-life care in patients with implantable cardioverter defibrillators: a MADIT-II substudy.
    Sherazi S; McNitt S; Aktas MK; Polonsky B; Shah AH; Moss AJ; Daubert JP; Zareba W
    Pacing Clin Electrophysiol; 2013 Oct; 36(10):1273-9. PubMed ID: 23731284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing Knowledge about Implantable Cardioverter Defibrillators at the End of Life, an Effective Approach for Hospice Workers to Improve Patient Care.
    Newcomer K; Godfrey S; Kumar S; Lorusso N; Patel N; Garrett B; Chen C; Sulistio MS
    J Pain Symptom Manage; 2024 May; 67(5):e409-e415. PubMed ID: 38331233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients' perspective on deactivation of the implantable cardioverter-defibrillator near the end of life.
    Pedersen SS; Chaitsing R; Szili-Torok T; Jordaens L; Theuns DA
    Am J Cardiol; 2013 May; 111(10):1443-7. PubMed ID: 23490027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deactivation of implantable cardioverter-defibrillators at end of life.
    Pettit SJ; Jackson CE; Gardner RS
    Future Cardiol; 2013 Nov; 9(6):885-96. PubMed ID: 24180544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deactivation of implantable cardioverter-defibrillators: results of patient surveys.
    Herman D; Stros P; Curila K; Kebza V; Osmancik P
    Europace; 2013 Jul; 15(7):963-9. PubMed ID: 23447573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implantable cardioverter-defibrillator deactivation at the end of life: a physician survey.
    Kelley AS; Reid MC; Miller DH; Fins JJ; Lachs MS
    Am Heart J; 2009 Apr; 157(4):702-8.e1. PubMed ID: 19332199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Documented consent process for implantable cardioverter-defibrillators and implications for end-of-life care in older adults.
    Niewald A; Broxterman J; Rosell T; Rigler S
    J Med Ethics; 2013 Feb; 39(2):94-7. PubMed ID: 23139392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implantable cardioverter defibrillator (ICD) deactivation discussions: Reality versus recommendations.
    Hill L; McIlfatrick S; Taylor BJ; Dixon L; Cole BR; Moser DK; Fitzsimons D
    Eur J Cardiovasc Nurs; 2016 Feb; 15(1):20-9. PubMed ID: 25903823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adverse experiences with implantable defibrillators in Oregon hospices.
    Fromme EK; Stewart TL; Jeppesen M; Tolle SW
    Am J Hosp Palliat Care; 2011 Aug; 28(5):304-9. PubMed ID: 21112878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physicians' preferences and attitudes about end-of-life care in patients with an implantable cardioverter-defibrillator.
    Sherazi S; Daubert JP; Block RC; Jeevanantham V; Abdel-Gadir K; DiSalle MR; Haley JM; Shah AH
    Mayo Clin Proc; 2008 Oct; 83(10):1139-41. PubMed ID: 18828973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality dying: An approach to ICD deactivation in the hospital setting.
    Turner S; Torabi S; Stilos K
    Am J Hosp Palliat Care; 2020 Sep; 37(9):664-668. PubMed ID: 32126793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in time in the management of the implantable cardioverter defibrillator in the last phase of life: a retrospective study of medical records.
    Stoevelaar R; Brinkman-Stoppelenburg A; van Driel AG; Theuns DA; Bhagwandien RE; van Bruchem-Visser RL; Lokker IE; van der Heide A; Rietjens JA
    Eur J Cardiovasc Nurs; 2019 Aug; 18(6):449-457. PubMed ID: 30995145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving rates of implantable cardioverter defibrillator deactivation in end-of-life care.
    Javaid MR; Squirrell S; Farooqi F
    BMJ Open Qual; 2018; 7(2):e000254. PubMed ID: 29713689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving implantable cardioverter defibrillator deactivation discussions in admitted patients made DNR and comfort care.
    Choi DY; Wagner MP; Yum B; Jannat-Khah DP; Mazique DC; Crossman DJ; Lee JI
    BMJ Open Qual; 2019; 8(4):e000730. PubMed ID: 31922034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implantable cardioverter defibrillator knowledge and end-of-life device deactivation: A cross-sectional survey.
    McEvedy SM; Cameron J; Lugg E; Miller J; Haedtke C; Hammash M; Biddle MJ; Lee KS; Mariani JA; Ski CF; Thompson DR; Chung ML; Moser DK
    Palliat Med; 2018 Jan; 32(1):156-163. PubMed ID: 28678000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ICD deactivation: review of literature and clinical recommendations.
    Thanavaro JL
    Clin Nurs Res; 2013 Feb; 22(1):36-50. PubMed ID: 22645402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.